HIST1H2BB Antibody

What is HIST1H2BB and why is it important in epigenetic research?

HIST1H2BB is one of several histone H2B variants that form part of the nucleosome core. Histones play central roles in transcription regulation, DNA repair, DNA replication, and chromosomal stability. DNA accessibility is regulated via modifications of histone tails and variations in nucleosome composition .

In epigenetic research, HIST1H2BB is particularly important due to its post-translational modifications (PTMs) that serve as epigenetic markers affecting chromatin structure and gene expression. Recent studies have also linked HIST1H2BB methylation status to cancer progression, particularly in high-grade serous ovarian carcinoma (HGSC) .

How do I select the appropriate HIST1H2BB antibody for my experiment?

Selection should be based on several critical factors:

• Target epitope specificity: Determine whether you need an antibody recognizing:

  • Total HIST1H2BB protein

  • Specific post-translational modifications (e.g., acLys5, acLys20)

  • Particular amino acid regions

• Application compatibility: Verify validated applications for your intended use:

• Host species: Consider potential cross-reactivity with your experimental system .

• Clonality: Monoclonal antibodies provide higher specificity for single epitopes, while polyclonal antibodies can offer greater sensitivity by recognizing multiple epitopes .

What is the optimal protocol for detecting HIST1H2BB in Western blots?

For optimal Western blot detection of HIST1H2BB:

• Sample preparation:

  • Use RIPA buffer for cell lysis followed by brief sonication

  • Determine protein concentrations using BCA assay

  • Boil samples at 100°C for 5 minutes with loading buffer

• Gel electrophoresis:

  • Use SDS-PAGE gels appropriate for small proteins (~14-17 kDa)

  • Transfer to PVDF membrane

• Blocking and antibody incubation:

  • Block with Odyssey Blocking Buffer or 5% non-fat dry milk in TBST

  • Incubate with primary anti-HIST1H2BB antibody at recommended dilutions (typically 1:1000-1:5000)

  • Follow with appropriate secondary antibody

• Important considerations:

  • Include serial dilutions of protein lysates for quantitative evaluation

  • Use reversibly stained proteins (like Ponceau S) as loading controls

  • Expected molecular weight is 14-17 kDa

How can I optimize ChIP protocols specifically for HIST1H2BB?

Chromatin immunoprecipitation (ChIP) for HIST1H2BB requires special considerations:

• Crosslinking and chromatin preparation:

  • Standard formaldehyde crosslinking (1% for 10 minutes)

  • Sonication conditions must be optimized to obtain fragments of 200-500 bp

• Antibody selection:

  • Use ChIP-validated antibodies specifically (e.g., ChIP grade antibodies like ab52484)

  • Perform preliminary validation with positive controls (e.g., HeLa acid extract)

• Controls and validation:

  • Include IgG negative controls

  • Use known HIST1H2BB-enriched regions as positive controls

  • Validate enrichment by qPCR before proceeding to sequencing

• Data analysis considerations:

  • When analyzing H2B variants, be aware of sequence similarity issues

  • Use appropriate normalization methods (input normalization recommended)

What methods should I use to study HIST1H2BB acetylation at specific lysine residues?

Research on specific HIST1H2BB acetylation sites requires:

• Antibody selection:

  • Use antibodies specific to particular modified lysine residues:

    • acLys5 - available as ABIN7139184

    • acLys16 - available from commercial sources

    • acLys20 - available as M12718

• Validation approaches:

  • Confirm specificity via peptide competition assays

  • Test cross-reactivity with non-modified lysine residues

  • Validate with positive and negative controls

• Experimental methods:

  • For global levels: Western blot with modification-specific antibodies

  • For genome-wide distribution: ChIP-seq with modification-specific antibodies

  • For site-specific confirmation: Mass spectrometry

• Data interpretation:

  • Compare with total HIST1H2BB levels

  • Analyze in context of other histone modifications (potential crosstalk)

How can I prevent degradation of HIST1H2BB during extraction and analysis?

HIST1H2BB modifications, particularly ubiquitination, are highly labile. To prevent degradation:

• Extraction procedures:

  • Use quick boiling methods for total histone extraction

  • Add protease inhibitors and deubiquitinase inhibitors (e.g., N-Ethylmaleimide)

  • Keep samples cold throughout processing

• Storage considerations:

  • Store antibodies at -20°C, avoiding repeated freeze/thaw cycles

  • Consider aliquoting into single-use fractions

  • For long-term storage of samples, use 50% glycerol/PBS with 0.02% sodium azide

• Detection optimization:

  • For H2B monoubiquitination detection, use sectioned blot probing approach

  • Consider serial dilution of protein lysates for accurate quantification

  • Use reversibly stained proteins as loading controls

Why might there be discrepancies between HIST1H2BB detection methods in my experiments?

Discrepancies may arise from several factors:

• Antibody specificity issues:

  • Cross-reactivity with other H2B variants (high sequence similarity)

  • Epitope masking due to complex formation or PTMs

  • Clone-dependent variability in recognition

• Sample preparation differences:

  • Native versus denaturing conditions yield different results

  • Chromatin-bound versus soluble fractions show different patterns

  • Fixation methods affect epitope accessibility

• Technical considerations:

  • H2B variants are small proteins (~14 kDa) that may require special running conditions

  • C-terminal epitope tagging can alter HIST1H2BB modification levels and detection

  • Some antibodies recognize only specific conformational states

• Recommendation: Always validate with multiple antibodies and detection methods when studying HIST1H2BB.

How is HIST1H2BB methylation being used as a biomarker in ovarian cancer?

Recent research has identified HIST1H2BB promoter methylation as a potential biomarker in high-grade serous ovarian carcinoma (HGSC):

• Key findings:

  • HIST1H2BB promoter methylation is differentially regulated in HGSC compared to normal fallopian tube samples

  • Higher methylation levels correlate with long-term survival in HGSC patients

  • HIST1H2BB has been identified as a potential tumor suppressor gene

• Methodological approaches:

  • Methylation detection using quantitative Methylation-Specific PCR (qMSP)

  • Analysis in multiple sample types: tissue, ascites, plasma/serum, vaginal swabs, and urine

  • Integration with somatic mutation profiling

• Clinical applications:

  • Potential for non-invasive detection in liquid biopsies

  • Prognostic indicator for patient survival

  • Possible therapeutic target for epigenetic therapy

What role do HIST1H2BB mutations play in cancer development and progression?

HIST1H2BB mutations have significant implications in cancer:

• Somatic mutations:

  • Mutations in HIST1H2BB and other H2B genes (particularly at Glu76) are frequently found in cancer cells

  • H2B E76K mutation (Glu76 replaced by Lys) is the predominant substitution

• Structural effects:

  • H2B E76K mutation distorts the interface between H2B and H4 in the nucleosome

  • This leads to nucleosome instability both in vivo and in vitro

  • H2A-H2B E76K complexes are weakly associated in the nucleosome (thermal stability ~10°C lower)

• Functional consequences:

  • Exogenous production of H2B E76K mutant enhances colony formation ability

  • Even in the presence of wild-type H2B, the mutant can promote oncogenic transformation

  • The mutation disrupts the binding of H2A-H2B E76K to H3-H4 without DNA

• Research implications: These findings suggest that even single amino acid substitutions in histone variants can significantly impact chromatin stability and cellular transformation.

How is HIST1H2BB expression related to endocrine resistance in breast cancer?

HIST1H2BB has emerged as a potential factor in endocrine-resistant breast cancer:

• Expression patterns:

  • HIST1H2BB mRNA expression is significantly higher in aromatase inhibitor (AI)-resistant tumors compared to sensitive tumors

  • Hypomethylation of HIST1H2BB correlates with increased expression in resistant cells

• Experimental evidence:

  • Stable overexpression of HIST1H2BB in MCF-7 cells (10-13 fold increase) affects cell proliferation

  • Both overexpression and downregulation caused decreased proliferation, suggesting tight regulation is needed

  • Expression varies across breast cancer cell lines without restriction to specific molecular subtypes

• Clinical relevance:

  • Analysis of AI-treated ER+ breast tumors showed significant association between HIST1H2BB expression and treatment resistance

  • Nanostring analysis identified 22 histone variant genes overexpressed in endocrine-resistant tumors

  • TCGA analysis showed frequent amplification of the HIST1 locus

How can I design experiments to study trans-histone crosstalk involving HIST1H2BB?

Trans-histone crosstalk, particularly involving H2B ubiquitination and other modifications, requires specialized approaches:

• Experimental design for H2B monoubiquitination (H2Bub1) studies:

  • Use commercial antibodies that recognize yeast H2B and cross-react with monoubiquitinated H2B at K120

  • Avoid C-terminal epitope-tagging of H2B as it can alter steady-state levels of H2Bub1

  • Implement sectioned blot probing combined with serial dilution of protein lysates

• Crosstalk analysis methods:

  • Sequential ChIP (Re-ChIP) to identify co-occurrence of modifications

  • Genetic approaches with mutation of writer enzymes

  • Salt-dependent nucleosome disruption assays to assess stability

  • Chromatin association assays for global changes in protein levels

• Important considerations:

  • H2Bub1 stabilizes nucleosomes by preventing H2A-H2B eviction

  • This provides a platform for Set1-COMPASS and Dot1 to promote methylation

  • Understanding requires both global and gene-specific approaches

What are the emerging methods for antibody-based profiling of HIST1H2BB in single cells?

Single-cell analysis of HIST1H2BB is advancing through several techniques:

• Single-cell immunofluorescence approaches:

  • Multiplexed immunofluorescence with specific anti-HIST1H2BB antibodies

  • Confocal microscopy for subcellular localization

  • Quantitative image analysis for expression levels

• Flow cytometry applications:

  • Intracellular staining protocols using fixation and permeabilization

  • Typical usage: ~0.40 μg antibody per 10^6 cells in 100 μl suspension

  • Can be combined with other markers for multiparametric analysis

• Emerging technologies:

  • CUT&RUN and CUT&Tag for locus-specific profiling at single-cell resolution

  • Mass cytometry (CyTOF) for multiplexed histone modification analysis

  • Single-cell ChIP-seq adaptations for genome-wide profiling

How can computational approaches enhance antibody specificity prediction for HIST1H2BB variants?

Recent advances in computational approaches for antibody specificity include:

• Modeling approaches:

  • Identification of different binding modes associated with particular ligands

  • Disentangling binding modes even for chemically similar ligands

  • Computational design of antibodies with customized specificity profiles

• Implementation strategies:

  • Use high-throughput sequencing data from phage display experiments

  • Train computational models on multiple datasets

  • Validate with novel antibody sequences not in training sets

• Applications for HIST1H2BB research:

  • Design antibodies with high specificity for particular HIST1H2BB variants

  • Create reagents that recognize specific post-translational modifications

  • Develop cross-specific antibodies for multiple target ligands

• Experimental validation: All computationally designed antibodies must undergo rigorous experimental validation before use in research applications.

What are the emerging roles of HIST1H2BB in reproductive biology and fertility?

Recent research has uncovered connections between histone H2B variants and fertility:

• Testis-specific H2B variants:

  • H2B.W1 (previously called H2BFWT) is a testis-specific H2B variant in primates

  • Single-nucleotide polymorphisms (SNPs) in H2B.W1 are associated with male non-obstructive infertility

  • H2B.W1 is expressed specifically in mid-late spermatogonia stages

• Functional impacts:

  • H2B.W1 creates more flexible nucleosome structures due to weakened DNA-histone interactions

  • The H2B.W1-H100R SNP further destabilizes nucleosomes by disrupting interactions with H4

  • These effects may alter chromatin structure during spermatogenesis

• Research implications for HIST1H2BB:

  • Comparison studies between canonical HIST1H2BB and testis-specific variants

  • Investigation of potential roles in chromatin remodeling during gametogenesis

  • Exploration of similar structural mechanisms in different cellular contexts

How can I design experiments to study the functional impact of HIST1H2BB acetylation on nucleosome stability?

To study how HIST1H2BB acetylation affects nucleosome stability:

• In vitro approaches:

  • Reconstitute nucleosomes with acetylated and non-acetylated HIST1H2BB

  • Perform thermal stability assays to detect histone dissociation

  • Use SYPRO Orange as a fluorescent probe to generate thermal denaturation curves

  • Compare dissociation temperatures between modified and unmodified samples

• Structural analysis:

  • Crystallography to determine atomic-level structural changes

  • Molecular dynamics simulations to assess dynamic effects

  • Gel filtration chromatography to evaluate histone complex formation

• Functional assays:

  • Salt-dependent nucleosome disruption assays

  • Accessibility assays using nucleases or transposases

  • Assessment of DNA-histone interactions using FRET or other biophysical techniques

• Cellular approaches:

  • Generate acetylation-mimicking mutants (e.g., K→Q) or non-acetylatable mutants (K→R)

  • Assess effects on chromatin association using ChIP or other chromatin fractionation methods

  • Evaluate functional outcomes on transcription and DNA repair